//
Dr Ralph And Marian Falk Medical Research Trust is a private corporation based in DALLAS, TX. The foundation received its IRS ruling in 1992. The principal officer is % Bank Of America. It holds total assets of $146.2M. Annual income is reported at $66.8M. According to available records, Dr Ralph And Marian Falk Medical Research Trust has made 41 grants totaling $23.7M, with a median grant of $200K. Annual giving has grown from $6.9M in 2021 to $16.8M in 2022. Individual grants have ranged from $60K to $6.9M, with an average award of $578K. The foundation has supported 21 unique organizations. The foundation primarily supports organizations in Rhode Island, Ohio, Wisconsin, which account for 37% of all grants. Grantmaking reaches organizations across 12 states. Contributions to this foundation are tax-deductible.
Dr Ralph And Marian Falk Medical Research Trust is a private foundation that provides grants to eligible organizations. Based on available records, the foundation has funded 41 grants. Its grantmaking reaches organizations primarily in RI, OH, WI.
Dr Ralph And Marian Falk Medical Research Trust has distributed a total of $23.7M across 41 grants. The median grant size is $200K, with an average of $578K. Individual grants have ranged from $60K to $6.9M.
The application deadline is PREFERENCE IS ACADEMIC RESEARCH INSTITUTIONS. ALL GRANTS ARE FOR RESEARCH OF DISEASES WITH. NO KNOWN CURE.
Dr Ralph And Marian Falk Medical Research Trust is headquartered in DALLAS, TX. While based in TX, the foundation distributes grants to organizations across 12 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Bank Of America N A | TRUSTEE | $738K | $0 | $738K |
Total Giving
$9.4M
Total Assets
$145.9M
Fair Market Value
N/A
Net Worth
$145.9M
Grants Paid
N/A
Contributions
$0
Net Investment Income
$6M
Distribution Amount
$8.3M
Total Grants
41
Total Giving
$23.7M
Average Grant
$578K
Median Grant
$200K
Unique Recipients
21
Most Common Grant
$200K
of 2022 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Medical College Of WisconsinRESEARCH FOR CHRONIC PAIN; | Milwaukee, WI | $1.2M | 2022 |
| Childrens Hospital Medical CenterRESEARCH FOR PARKINSONS, | Cincinnati, OH | $1.1M | 2022 |
| Yale University School Of MedicineDEVELOPE CANCER VACCINES; | New Haven, CT | $1.1M | 2022 |
| Cleveland Clinic FoundationGLIOBLASTOMA TREATMENTS & | Cleveland, OH | $1.1M | 2022 |
| Regents Of University Of MichiganDEVICE TO PREDICT | Pittsburgh, PA | $870K |
| 2022 |
| Stanford UniversityBIOMARKERS FOR IMMUNE | Menlo Park, CA | $460K | 2022 |
| Michigan State UniversityNOVEL RXR AGONIST FOR | East Lansing, MI | $400K | 2022 |
| Indiana UniversityTARGETING PEANUT-SPECIFIC | Detroit, MI | $320K | 2022 |
| Case Western Reserve UniversityIMMUNOTHERAPY FOR B CELL | Cleveland, OH | $260K | 2022 |
| Ohio State UniversityOPTIMIZINGN BTK INHIBITOR | Columbus, OH | $200K | 2022 |
| Northwestern UniversityNEOANTIGEN INDUCERS AS | Evanstone, IL | $200K | 2022 |
| University Of Iowa Research FoundationPIEZOELECTRIC IMMUNOSENSOR | Iowa City, IA | $200K | 2022 |
| University Of ChicagoINSTATISTICAL DESIGN OF | Chicago, IL | $200K | 2022 |
| Regents Of The Univ Of MinnesotaELECTRICAL BRAIN CIRCUIT | Minneapolis, MN | $200K | 2022 |
| Rush University Medical CenterANTI-HIV ANTIBODIES TO | Chicago, IL | $200K | 2022 |
| Kumc RiEULICIDATING THE ROLE OF | Kansas City, KS | $200K | 2022 |
| Brown University Of Providence 9998ANTI-MALARIA DRUGS TARGETNG | Providence, RI | $60K | 2022 |
| University Of CincinnatiHUMANIZED ANTIBODY | Cleveland, ND | $60K | 2022 |
| Board Of Trustees U Of IllinoisALZHEIMERS DISEASE | Chicago, IL | $60K | 2022 |
| Board Regents Of U Of WisconsinIMMUNOTHERAPY TRIPLE | Milwaukee, WI | $60K | 2022 |
| See AttachedUNRESTRICTED GENERAL | See Attached, RI | $6.9M | 2021 |
HOUSTON, TX
© 2026 Granted AI